Business Description
Surmodics Inc
NAICS : 325413
SIC : 3845
ISIN : US8688731004
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.22 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | 1.14 | |||||
Interest Coverage | 5.19 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 7.25 | |||||
Beneish M-Score | -2.97 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.2 | |||||
3-Year EBITDA Growth Rate | 33.9 | |||||
3-Year EPS without NRI Growth Rate | 24 | |||||
3-Year FCF Growth Rate | -10.3 | |||||
3-Year Book Growth Rate | -4 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.17 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.73 | |||||
9-Day RSI | 62.64 | |||||
14-Day RSI | 62.79 | |||||
6-1 Month Momentum % | -18.95 | |||||
12-1 Month Momentum % | 50.3 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.39 | |||||
Quick Ratio | 3.59 | |||||
Cash Ratio | 2.13 | |||||
Days Inventory | 76.53 | |||||
Days Sales Outstanding | 30.62 | |||||
Days Payable | 15.75 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.2 | |||||
Shareholder Yield % | -2.08 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.26 | |||||
Operating Margin % | 12.92 | |||||
Net Margin % | 9.44 | |||||
FCF Margin % | 15.8 | |||||
ROE % | 11.62 | |||||
ROA % | 7.47 | |||||
ROIC % | 10.68 | |||||
ROC (Joel Greenblatt) % | 53.85 | |||||
ROCE % | 13.15 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 36.19 | |||||
PE Ratio without NRI | 35.85 | |||||
Shiller PE Ratio | 201.63 | |||||
Price-to-Owner-Earnings | 33.35 | |||||
PS Ratio | 3.39 | |||||
PB Ratio | 3.96 | |||||
Price-to-Tangible-Book | 8.81 | |||||
Price-to-Free-Cash-Flow | 21.49 | |||||
Price-to-Operating-Cash-Flow | 18.8 | |||||
EV-to-EBIT | 23.16 | |||||
EV-to-EBITDA | 16.32 | |||||
EV-to-Revenue | 3.38 | |||||
EV-to-Forward-Revenue | 3.91 | |||||
EV-to-FCF | 21.41 | |||||
Price-to-Projected-FCF | 3.53 | |||||
Price-to-Median-PS-Value | 0.63 | |||||
Price-to-Graham-Number | 3.75 | |||||
Price-to-Net-Current-Asset-Value | 19.26 | |||||
Earnings Yield (Greenblatt) % | 4.32 | |||||
FCF Yield % | 4.6 | |||||
Forward Rate of Return (Yacktman) % | -15.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Surmodics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 132.067 | ||
EPS (TTM) (€) | 0.883 | ||
Beta | 0.8 | ||
Volatility % | 80.74 | ||
14-Day RSI | 62.79 | ||
14-Day ATR (€) | 0.628033 | ||
20-Day SMA (€) | 29.59 | ||
12-1 Month Momentum % | 50.3 | ||
52-Week Range (€) | 16.2 - 35.2 | ||
Shares Outstanding (Mil) | 14.26 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Surmodics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Surmodics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Surmodics Inc Frequently Asked Questions
What is Surmodics Inc(FRA:SU6)'s stock price today?
When is next earnings date of Surmodics Inc(FRA:SU6)?
Does Surmodics Inc(FRA:SU6) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |